Similar articles

• Licensure of screening tests for antibody to human T-lymphotropic virus type I.

  Centers for Disease Control (CDC). Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1988 Dec 9;37(48):736-40, 745-7. MMWR Morb Mortal Wkly Rep. 1988. PMID: 3143058 No abstract available.
• The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

  Manns A, Blattner WA. Manns A, et al. Transfusion. 1991 Jan;31(1):67-75. doi: 10.1046/j.1537-2995.1991.31191096189.x. Transfusion. 1991. PMID: 1986467 Review. No abstract available.
• HTLV-I infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques.

  Moynet D, Berteau F, Astier-Gin T, Legrand E, Sainte-Foie S, Joly F, Moreau JP, Guillemain B. Moynet D, et al. Leukemia. 1992;6 Suppl 3:106S-109S. Leukemia. 1992. PMID: 1602804 No abstract available.
• Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil.

  Andrade TM, Dourado I, Galvão-Castro B. Andrade TM, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):186-7. doi: 10.1097/00042560-199806010-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9637584 No abstract available.
• [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].

  Christiansen CB. Christiansen CB. Ugeskr Laeger. 1994 Dec 19;156(51):7663-7. Ugeskr Laeger. 1994. PMID: 7839528 Review. Danish.